Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1025 of 2873 entries
View as:

Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02096042 Org: User:
Start: 04/30/14 End: 08/31/16 Due: 08/31/17

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02744053 Org: User:
Start: 11/07/16 End: 04/30/26 Due: 04/30/27

ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00533169 Org: User:
Start: 09/30/07 End: 02/28/11 Due: 02/28/12

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Phase: N/A Priority: Normal
NCT ID: NCT01266070 Org: User:
Start: 11/30/12 End: 12/31/15 Due: 12/31/16

An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)

Phase: N/A Priority: Normal
NCT ID: NCT01498445 Org: User:
Start: 06/12/12 End: 09/24/19 Due: 09/24/20

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06043323 Org: User:
Start: 01/08/24 End: 09/01/28 Due: 09/01/29

A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy

Phase: N/A Priority: Normal
NCT ID: NCT06085625 Org: User:
Start: 11/26/24 End: 11/01/27 Due: 11/01/28

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01154920 Org: User:
Start: 07/09/10 End: 12/31/25 Due: 12/31/26

An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01619774 Org: User:
Start: 09/30/12 End: 08/31/15 Due: 08/31/16

Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00948129 Org: User:
Start: 08/10/09 End: 02/10/21 Due: 02/10/22

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00038376 Org: User:
Start: 05/08/90 End: 06/30/05 Due: 06/30/06

The Role of the EKG in Anticancer Drug Development

Phase: N/A Priority: Normal
NCT ID: NCT01462383 Org: User:
Start: 01/31/11 End: 11/30/11 Due: 11/30/12

2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II

Phase: N/A Priority: Normal
NCT ID: NCT03941769 Org: User:
Start: 09/29/20 End: 03/01/23 Due: 03/01/24

Bevacizumab in Multiple Phase I Combinations

Phase: N/A Priority: Normal
NCT ID: NCT00543504 Org: User:
Start: 10/10/07 End: 04/29/20 Due: 04/29/21

Bendamustine in Acute Leukemia and MDS

Phase: N/A Priority: Normal
NCT ID: NCT00790855 Org: User:
Start: 11/30/08 End: 03/31/12 Due: 03/31/13

Reducing Cancer Disparities Among Latinos in Texas

Phase: N/A Priority: Normal
NCT ID: NCT01504919 Org: User:
Start: 01/31/12 End: 01/18/22 Due: 01/18/23

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

Phase: N/A Priority: Normal
NCT ID: NCT01902966 Org: User:
Start: 09/11/13 End: 08/14/20 Due: 08/14/21

Sublingual Fentanyl for the Management of Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT02514252 Org: User:
Start: 02/02/16 End: 11/04/19 Due: 11/04/20

Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage

Phase: N/A Priority: Normal
NCT ID: NCT00905034 Org: User:
Start: 03/31/09 End: 02/28/15 Due: 02/28/16

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT00813124 Org: User:
Start: 12/31/08 End: 09/30/14 Due: 09/30/15

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

Phase: N/A Priority: Normal
NCT ID: NCT04708054 Org: User:
Start: 10/21/21 End: 12/31/27 Due: 12/31/28

Identification and Treatment of Depression

Phase: N/A Priority: Normal
NCT ID: NCT00863200 Org: User:
Start: 03/31/09 End: 02/12/19 Due: 02/12/20

Pancreatic Cancer Genetic Epidemiology (PACGENE) Study

Phase: N/A Priority: Normal
NCT ID: NCT00526578 Org: User:
Start: 06/19/02 End: 06/30/25 Due: 06/30/26

Combining Varenicline and Bupropion for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00943618 Org: User:
Start: 05/17/10 End: 09/09/21 Due: 09/09/22

POWER UP: Participating Online While Exercising to Recover Using Play

Phase: N/A Priority: Normal
NCT ID: NCT05308407 Org: User:
Start: 05/04/22 End: 10/31/25 Due: 10/31/26